Myasthenia gravis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001337:Autonomic Agents / Q000494:pharmacology / Q000627:therapeutic use; D004576:Electromyography; D005260:Female; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D007773:Lactates / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000187:drug effects / Q000294:innervation; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000188:drug therapy / Q000451:nursing / Q000473:pathology* / Q000503:physiopathology; D009469:Neuromuscular Junction / Q000187:drug effects / Q000503:physiopathology; D011241:Prednisone / Q000627:therapeutic use; D012119:Respiration / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects; D013950:Thymus Gland / Q000503:physiopathology
D000889:Anti-Arrhythmia Agents; D000900:Anti-Bacterial Agents; D001337:Autonomic Agents; D005938:Glucocorticoids; D007773:Lactates; D011241:Prednisone